Talian Hotline Kami
+603 - 8230 0300
Utama
Pengenalan
Latar Belakang
Visi, Misi & Nilai Teras
Objektif
Carta Organisasi
Kod Etika dan Tatakelakuan
Board of Directors
Top Management Team of MDA
Malaysian Leadership
Former CEO of MDA
Bahagian
Pejabat Ketua Eksekutif
Unit Komunikasi Korporat
Unit Undang-undang
Unit Integriti
Secretarial Unit
Bahagian Pendaftaran, Pelesenan Dan Penguatkuasaan
Post Market & Enforcement Division
Policy & Strategic Planning Division
International and Industry Affairs Division
Unit Pengurusan Dan Perkhidmatan
Soalan Lazim
Single License Policy Implementation
Pendaftaran, Pelesenan & Penguatkuasaan
Labelling of Medical Devices
Technical Evaluation
Hubungi
Borang Aduan Pelanggan
Direktori Kakitangan
Dokumen
Perundangan
Surat Pekeliling
Dokumen Panduan
Garis panduan
Standard
General Directions
Strategic Plan
Persembahan Slide
Infographic
Organizational Anti Corruption Plan (OACP) MDA 2022 - 2026
Buletin MDA
Press Release
Media Coverage (Newspaper Cutting)
Laporan Tahunan
Customer Satisfaction Survey
Customer Satisfaction Survey Result
Laporan Kajian Kepuasan Pelanggan
Cari
fas fa-search
Laman Utama
Pengumuman
Filters
Penapis Tajuk
Papar #
5
10
15
20
25
30
50
100
Semua
Filter
Tajuk
Dikunjungi
PENGUMUMAN PEMBATALAN KELULUSAN BERSYARAT (CONDITIONAL APPROVAL) KIT UJIAN KENDIRI COVID - 19
Dikunjungi: 8608
Online Training By The Authority: ISO 13485:2016 Quality Management System For Medical Devices - 9 & 10 August 2022
Dikunjungi: 9618
Pengumuman MEDCREST
Dikunjungi: 10505
Hands-On Workshop: Efficient Way To Prepare For MDA Documentation Submissions (27 - 28 Julai 2022)
Dikunjungi: 4596
SPECIAL ACCESS LIST OF COVID-19 TEST KIT (FOR PROFESSIONAL USE ONLY)
Dikunjungi: 41098
PENGUATKUASAAN SEPENUHNYA PERATURAN PERANTI PERUBATAN (TANGGUNGJAWAB & OBLIGASI ESTABLISMEN) 2019 MULAI 1 JULAI 2022
Dikunjungi: 8460
PENGUMUMAN: KEPERLUAN PELABELAN PERANTI PERUBATAN
Dikunjungi: 7881
[OFFICIAL ANNOUNCEMENT] SEMINAR BY THE MEDICAL DEVICE AUTHORITY ON REGULATORY UPDATES – 5 JULY 2022
Dikunjungi: 15906
PENGUMUMAN SURAT PEKELILING PIHAK BERKUASA PERANTI PERUBATAN (MDA) BIL 1/2022: PENGECUALIAN PROSES PENILAIAN PEMATUHAN OLEH BADAN PENILAIAN PEMATUHAN (CAB) BAGI PENDAFTARAN KIT UJIAN COVID-19
Dikunjungi: 8700
PENGUMUMAN SURAT PEKELILING PIHAK BERKUASA PERANTI PERUBATAN (MDA) BIL 2/2022: KAWALAN TERHADAP PERANTI PERUBATAN ORPHANED, OBSOLETE DAN DISCONTINUED DI HOSPITAL, INSTITUSI KEMUDAHAN KESIHATAN ATAU MANA-MANA FASILITI YANG BERKAITAN
Dikunjungi: 7401
16
17
18
19
20
21
22
23
24
25
Halaman 21 dari 40
Utama
Pengenalan
Latar Belakang
Visi, Misi & Nilai Teras
Objektif
Carta Organisasi
Kod Etika dan Tatakelakuan
Board of Directors
Top Management Team of MDA
Malaysian Leadership
Former CEO of MDA
Bahagian
Pejabat Ketua Eksekutif
Unit Komunikasi Korporat
Unit Undang-undang
Unit Integriti
Secretarial Unit
Bahagian Pendaftaran, Pelesenan Dan Penguatkuasaan
Post Market & Enforcement Division
Policy & Strategic Planning Division
International and Industry Affairs Division
Unit Pengurusan Dan Perkhidmatan
Soalan Lazim
Single License Policy Implementation
Pendaftaran, Pelesenan & Penguatkuasaan
Labelling of Medical Devices
Technical Evaluation
Hubungi
Borang Aduan Pelanggan
Direktori Kakitangan
Dokumen
Perundangan
Surat Pekeliling
Dokumen Panduan
Garis panduan
Standard
General Directions
Strategic Plan
Persembahan Slide
Infographic
Organizational Anti Corruption Plan (OACP) MDA 2022 - 2026
Buletin MDA
Press Release
Media Coverage (Newspaper Cutting)
Laporan Tahunan
Customer Satisfaction Survey
Customer Satisfaction Survey Result
Laporan Kajian Kepuasan Pelanggan
×